CN105688103A - 一种治疗胸椎骨结核的中药制剂 - Google Patents
一种治疗胸椎骨结核的中药制剂 Download PDFInfo
- Publication number
- CN105688103A CN105688103A CN201610288822.3A CN201610288822A CN105688103A CN 105688103 A CN105688103 A CN 105688103A CN 201610288822 A CN201610288822 A CN 201610288822A CN 105688103 A CN105688103 A CN 105688103A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- gram
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 210000000115 thoracic cavity Anatomy 0.000 title claims abstract description 33
- 201000008827 tuberculosis Diseases 0.000 title claims abstract description 22
- 241000628997 Flos Species 0.000 claims abstract description 31
- 241000283956 Manis Species 0.000 claims abstract description 30
- 241000903946 Clematidis Species 0.000 claims abstract description 29
- 241000005787 Cistanche Species 0.000 claims abstract description 28
- 241000218176 Corydalis Species 0.000 claims abstract description 28
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 28
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 28
- 210000000582 semen Anatomy 0.000 claims abstract description 26
- 241001489978 Eupolyphaga Species 0.000 claims description 27
- 241000522620 Scorpio Species 0.000 claims description 27
- 239000009490 scorpio Substances 0.000 claims description 27
- 230000000694 effects Effects 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 27
- 210000004369 blood Anatomy 0.000 abstract description 26
- 208000002193 Pain Diseases 0.000 abstract description 21
- 210000004185 liver Anatomy 0.000 abstract description 21
- 230000001737 promoting effect Effects 0.000 abstract description 18
- 210000003734 kidney Anatomy 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 16
- 208000025865 Ulcer Diseases 0.000 abstract description 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract description 2
- 241000239226 Scorpiones Species 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000001338 necrotic effect Effects 0.000 abstract description 2
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 206010056377 Bone tuberculosis Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 9
- 206010000269 abscess Diseases 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 6
- 238000012913 prioritisation Methods 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000003001 spinal tuberculosis Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000036269 ulceration Effects 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000002513 Flank pain Diseases 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000004960 NAD(P)H dehydrogenase (quinone) Human genes 0.000 description 2
- 108020000284 NAD(P)H dehydrogenase (quinone) Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960003350 isoniazid Drugs 0.000 description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229960005206 pyrazinamide Drugs 0.000 description 2
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 206010023509 Kyphosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 201000011086 ureterolithiasis Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗胸椎骨结核的中药制剂,包括熟地20-30克、肉苁蓉10-20克、女贞子5-10克、莱菔子10-20克、淫羊藿5-10克、牛膝5-10克、威灵仙5-10克、甘草5-10克、地鳖虫10-20克、穿山甲8-15克、全蝎8-12克、百部8-12克、葛根8-12克、杜仲8-12克、麦芽8-12克、三七粉8-12克、红花10-15克、郁金10-15克、秦艽8-12克、元胡10-20克。诸药配伍精良,组方合理,共奏补肝益肾、养血活血、除瘀排脓、敛疡止痛,去腐生肌之功效,共同达到提高机体免疫防御能力,促进血液循环,杀灭病患区的结核杆菌,进而达到治愈胸椎骨结核的目的。
Description
技术领域
本发明属中药领域,特别是涉及一种治疗胸椎骨结核的中药制剂。
背景技术
胸椎骨结核属于骨结核的一种,是结核菌经过各种途径侵入胸椎引起的感染,是全身疾病在局部的表现形式。胸椎结核在脊柱结核中发生率高达39.6%左右,尤其儿童居多。由于胸腔负压、纵隔脏器搏动、胸廓出口毗邻结构复杂和胸椎生理性后凸等因素,胸椎结核易形成椎旁和它处流注脓肿,胸椎旁侧脓肿范围通常较为广泛,文献报道发生率为86.5%-98.5%。胸椎结核同其他脊柱结核一样好发于椎体,以破坏脊柱的前、中柱为主,又由于其本身存在的生理性后凸,应力集中在椎体的前侧,负重后造成椎体塌陷,导致后凸畸形十分明显。
目前治疗方法多为抗痨和有些民间偏方加上手术等传统治疗方式,结果使患者长期得不到有效治疗,由于抗痨药物的长期应用,容易造成系统损伤和严重损害肝脏系统,有的还会损伤第八对脑神经,造成听力下降而耳聋,手术治疗不仅费用高而且患者痛苦很大,丧失劳动能力。因此,近年来,我们根据中医辩症施治、标本兼治的原则,利用各种草药的不同药理药性,通过中药水煎剂来治疗胸椎骨结核,取得了良好的治疗效果,深受患者的欢迎和认可。
发明内容
本发明解决了目前在治疗胸椎骨结核方面存在的技术不足,提供了一种见效快、疗程短、治愈率高且无副作用的中药药剂。
本发明所采用的技术方案为:
一种治疗胸椎骨结核的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地20-30克、肉苁蓉10-20克、女贞子5-10克、莱菔子10-20克、淫羊藿5-10克、牛膝5-10克、威灵仙5-10克、甘草5-10克、地鳖虫10-20克、穿山甲8-15克、全蝎8-12克、百部8-12克、葛根8-12克、杜仲8-12克、麦芽8-12克、三七粉8-12克、红花10-15克、郁金10-15克、秦艽8-12克、元胡10-20克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地20克、肉苁蓉10克、女贞子5克、莱菔子10克、淫羊藿5克、牛膝5克、威灵仙5克、甘草5克、地鳖虫10克、穿山甲8克、全蝎8克、百部8克、葛根8克、杜仲8克、麦芽8克、三七粉8克、红花10克、郁金10克、秦艽8克、元胡10克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地22克、肉苁蓉12克、女贞子6克、莱菔子12克、淫羊藿6克、牛膝6克、威灵仙6克、甘草6克、地鳖虫12克、穿山甲9克、全蝎9克、百部9克、葛根9克、杜仲9克、麦芽9克、三七粉9克、红花11克、郁金11克、秦艽9克、元胡12克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地24克、肉苁蓉14克、女贞子7克、莱菔子14克、淫羊藿7克、牛膝7克、威灵仙8克、甘草7克、地鳖虫14克、穿山甲11克、全蝎9克、百部9克、葛根9克、杜仲8克、麦芽8克、三七粉8克、红花12克、郁金12克、秦艽9克、元胡12克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地26克、肉苁蓉16克、女贞子8克、莱菔子16克、淫羊藿8克、牛膝9克、威灵仙8克、甘草8克、地鳖虫16克、穿山甲12克、全蝎10克、百部10克、葛根11克、杜仲10克、麦芽10克、三七粉11克、红花13克、郁金13克、秦艽10克、元胡13克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地28克、肉苁蓉18克、女贞子9克、莱菔子18克、淫羊藿9克、牛膝9克、威灵仙9克、甘草9克、地鳖虫18克、穿山甲14克、全蝎11克、百部11克、葛根11克、杜仲11克、麦芽11克、三七粉11克、红花14克、郁金14克、秦艽11克、元胡18克。
作为一种优化方案,所述中药制剂由以下重量份的中药原材料组成:
熟地30克、肉苁蓉20克、女贞子10克、莱菔子20克、淫羊藿10克、牛膝10克、威灵仙10克、甘草10克、地鳖虫20克、穿山甲15克、全蝎12克、百部12克、葛根12克、杜仲12克、麦芽12克、三七粉12克、红花15克、郁金15克、秦艽12克、元胡20克。
上述药物的服用方法为:将熟地、肉苁蓉、女贞子、莱菔子、淫羊藿、牛膝、威灵仙、甘草、地鳖虫、穿山甲、全蝎、百部、葛根、杜仲、麦芽、三七粉、红花、郁金、秦艽、元胡按照一定重量配比(随症加减)混合后,按照传统煎制中药的方法水煎制,先用大火煮沸,小火煎熬,煎熬时搅拌药料2-3次,煎熬时间为60-90min,完成煎熬后滤去药渣,取药液。每日水煎一剂,分2次温服,30天为一疗程。
上述药物的原料中药:
熟地,味甘,性微温;归肝、肾经。具有养血滋阴,补精益髓之功效。
肉苁蓉,味甘、咸,性温;归肾、大肠经。具有补肾壮阳,强益精血,润肠通便之功效。
女贞子,性味甘,苦,平;归肝,肾经。具有补益肝肾,清虚热,强腰膝,明耳目,乌须发之功效。
莱菔子,味辛、甘,性平;归脾、胃、肺经。具有消食除胀,降气化痰之功效。现代药理研究,莱菔子素能够在动物机体各个组织器官内诱导产生Ⅱ相酶(脱毒酶)-谷胱甘肽转移酶(GST)和醌还原酶(QR),从而消除化学致癌物的侵害,对食道癌、结肠癌、乳腺癌等表现出良好的抗癌活性。
淫羊藿,味辛、甘,性温;归肝、肾经。具有补肾壮阳、祛风除湿、强健筋骨之功效。
牛膝,味苦、酸,性平;归肝、肾经。具有滋补肝肾,强筋壮骨,活血化瘀,利尿通淋之功效。《本草经疏》:牛膝,走而能补,性善下行,故入肝肾。主寒湿痿痹,四肢拘挛、膝痛不可屈伸者,肝脾肾虚,则寒湿之邪客之而成痹,及病四肢拘挛,膝痛不可屈伸。此药性走而下行,其能逐寒湿而除痹也必矣。盖补肝则筋舒,下行则理膝,行血则痛止。逐血气,犹云能通气滞血凝也。详药性,气当作痹。伤热火烂,血焦枯之病也,血行而活,痛自止矣。
威灵仙,味辛、咸、微苦,性温;小毒;归膀胱、肝经。威灵仙有祛风湿、通经络、消骨哽三大功效,因其性走窜,药理学证实其还有解除食管、支气管、输尿管、胃及胆道等处平滑肌痉挛的作用,并有较强的消炎止痛作用。
甘草,味甘,性平;归心、脾、肺、胃经。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药之功效,有解毒、祛痰、止痛、解痉以至抗癌等药理作用。甘草酸是甘草中最主要的活性成分。甘草酸及其系列产品,对肉瘤、癌细胞生长有抑制作用,对艾滋病的抑制率更高达90%,有较强的增加人体免疫功能作用。
地鳖虫,味咸,性寒;归肝经。具有破瘀血,续筋骨之功效。
穿山甲,味咸,性微寒;归肝、胃经。具有活血通经,下乳,消肿排脓之功效。穿山甲能引药下行,直达病灶内部,攻癌化瘤,使得肿块快速软化缩小,具有较好的抗癌作用。
全蝎,味辛,性平;归肝经。具有熄风止痉,解毒散结,通络止痛之功效。药理学研究证明,全蝎提取液能增强心脏收缩张力,有抑制动物血栓形成和抗凝作用。
百部,味甘、苦,性微温;归肺经。具有润肺止咳之功效。体外试验表明:百部煎剂及醇浸剂对肺炎球菌、乙型溶血性链球菌、脑膜炎球菌、金黄色葡萄球菌、白色葡萄球菌、痢疾杆菌、伤寒杆菌、副伤寒杆菌、大肠杆菌、变形杆菌、白喉杆菌、肺炎杆菌、鼠疫杆菌、炭疽杆菌、枯草杆菌以及霍乱弧菌、人型结核杆菌等均有不同程度的抑制作用。蔓生百部水浸液在体外对某些致病真菌有一定的抑制作用。百部煎剂能降低亚洲甲型流感病毒对小鼠的致病力,对已感染的小鼠亦有治疗作用。
葛根,性凉味甘辛,有解表退热,生津、透疹、升阳止泻等多种功能,可治外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热疹、泄泻等多种疾病。葛根中提出的黄酮能增加大脑及冠状血管血流量,降低血管阻力。所含的大豆黄酮具有解痉作用,还能降低血糖,并有解热及雌激素样作用。
杜仲,味甘,性温。归肝、肾、胃经。功效补益肝肾、强筋壮骨、调理冲任、固经安胎。治疗肾阳虚引起的腰腿痛或酸软无力。肝气虚引起的胞胎不固,阴囊湿痒等症。
麦芽,味甘,性平;归脾、胃、肝经。具有消食健胃,回乳消胀之功效。
三七粉,味甘、微苦,温;归心、肝、脾经。具有化瘀止血,消肿止痛之功效。
红花,味辛,性温;归心,肝经。具有活血通经,散瘀止痛之功效。《药品化义》:红花,善通利经脉,为血中气药,能泻而又能补,各有妙义。红花活血通经,散淤止痛,用于恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。本发明主要利用红花活血功效增强血液循环和皮肤新陈代谢。
郁金为血分之气药,既理气,又化瘀,辨证为气滞血瘀者常用本品。临床上有气滞血瘀的疾病,如心肌炎、冠心病胸闷胸痛或伴心绞痛、慢性肝病或伴门静脉高压、免疫病肺损害或伴肺动脉高压、慢性胆囊炎胆石症、输尿管结石伴血尿等,这些都需用理气化瘀的方法治疗,郁金是适用药,可与柴胡、白芍等同用。现代药理证明,郁金挥发油注射液能增强纤溶活性,并通过提高CAMP含量而明显抑制血小板聚集,因而能起到抗凝血的作用。
秦艽,苦能泄,辛能散,微温能通利,故主寒热邪气,寒湿风痹,肢节痛,下水,利小便,能祛风除湿。还可散一身风邪,引药直达病所,与养血活血之品,扶正祛邪,祛风通络治瘫。
元胡,味辛、苦,性温;归肝、脾经。具有理气止痛,活血散瘀之功效。
胸椎结核是脊柱结核及骨结核中十分常见的一种类型,发生于骨与关节间的结核性化脓性疾病。因其成脓后,可流窜于病变附近或较远的空隙处形成脓肿,破损后脓液稀薄如痰,故属于中医“流痰”、“骨痨”。中医认为,其病因多为先天不足,或久病肾阴亏损,骨髓不充,外邪乘虚而入,痰浊凝聚;或跌扑损伤,气血不和而诱发。病证初起局部酸胀微肿,不红、不热、不痛;久则漫肿疼痛成脓,周围肌肉萎缩;后期可伴有潮热、盗汗、乏力等阴亏火旺之证,且局部溃破流清稀脓液及败絮样物,久则形成窦道,不易收口。治疗当应用扶正和祛邪两大法则,扶正即调动机体抵抗力,增强免疫功能,达到抗痨强体的目的;祛邪即祛除体内湿热邪毒、消炎杀菌,敛疡止痛。
本发明药物中,熟地、肉苁蓉、女贞子、淫羊藿、牛膝、杜仲皆为滋补之要药,能补肾益肝、养血滋阴、补益精髓,起到调和冲任、调理脏腑功能、扶正驱邪,增强机体免疫力和抵抗能力的作用。威灵仙、秦艽、全蝎祛风除湿、通络止痛,驱散机体内湿热邪毒;百部、葛根清热解毒、润燥杀虫,对多种球菌、结核杆菌、皮肤真菌等均有抑制作用,具有较好的消炎抗菌功效;穿山甲、地鳖虫、元胡、三七粉、红花、郁金能活血化瘀、通经活络、消肿排毒,起到改善和恢复结核病灶血液循环、使药物更好的渗透,进而增强除祛瘀排脓的作用。莱菔子、麦芽消食化痰、和胃健脾,起到调理脏腑功能,疏通三焦,消除凝聚于椎骨的痰浊病毒;牛膝、穿山甲又能引药下行,增强破血逐瘀、通经活络之功;甘草既能补脾益气、清热解毒,又能调和诸药,使诸药之偏性得以缓解,而使之彼此协调,共同完成其治疗作用。
本方利用中医辨证理论,通过行气、补血解决胸椎骨与软组织的血液供应,通过补肾主要是因为肾主骨生髓的原因,通过活血化瘀、活络通脉解决骨头周围脉络不通,通过祛风湿、化热毒解决体内湿热邪毒,杀灭结核病菌。诸药配伍精良,组方合理,共奏补肝益肾、养血活血、除瘀排脓、敛疡止痛,去腐生肌之功效,共同达到提高机体免疫防御能力,促进血液循环,杀灭病患区的结核杆菌,进而达到治愈胸椎骨结核的目的。
为进一步考察本发明药物的临床疗效,我们选择了78例住院及门诊胸椎结核患者,年龄24~67岁,平均年龄(35.4±16.2)岁。其中男性30例,女性48例。全部患者均有不同程度的胸椎局部疼痛及结核菌感染症状,常伴有面色潮红、盗汗、消瘦、咳嗽、气短、乏力等症状。术前进行X线、CT等影像学检查,显示不同程度的椎体破坏,其中T3-4胸椎13例,T5-6胸椎17例,T7-8胸椎22例,T8-9胸椎11例,T9-10胸椎7例,T10-11胸椎8例。病程5~48个月。随机进行分组,分为治疗组和对照组各39例,两组患者在性别、年龄、病症等方面,经统计学比较无显著性差异(P>0.05),具有可比性。
治疗方法:
治疗组:将熟地、肉苁蓉、女贞子、莱菔子、淫羊藿、牛膝、威灵仙、甘草、地鳖虫、穿山甲、全蝎、百部、葛根、杜仲、麦芽、三七粉、红花、郁金、秦艽、元胡按照一定重量配比(随症加减)混合后,按照传统煎制中药的方法水煎制,先用大火煮沸,小火煎熬,煎熬时搅拌药料2-3次,煎熬时间为60~90min,完成煎熬后滤去药渣,取药液。每日水煎一剂,分2次温服,30天为一疗程。
对照组:口服异烟肼片,按体重每日口服5mg/kg.最高0.3g(3片);利福平胶囊,一日0.45g~0.60g,空腹顿服,每日不超过1.2g;吡嗪酰胺片,每日15~30mg/kg顿服,或50~70mg/kg,每周2~3次;每日服用者最高每日2g,每周3次者最高每次3g,每周服2次者最高每次4g;链霉素片,一日20mg/kg,隔日用药,同时口服维生素C,每日2次,每次一片。
疗效标准:
①痊愈:临床症状消失,行动自如,破溃者愈合。影像:破坏区缩小至消失,骨质密度恢复正常,脓肿消失,随访半年以上未复发。
②显效:症状消失、行动受限明显改善,破溃处愈合2/3。影像:边缘较清楚,破坏区正缩小,骨质密度渐恢复,脓肿缩小。
③有效:症状好转,行动受限有所改善,破溃处愈合不到1/2。影像:稍有改变或维持原样。
④无效:症状如影像维持原样无改变。
疗效结果:
1、临床疗效比较:
治疗后,治疗组治愈8例,显效12例,有效14例,无效5例,治愈率为20.5%,有效率达87.2%;对照组治愈2例,显效9例,有效16例,无效12例,治愈率为5.1%,有效率为41.0%;治疗组治愈率和有效率均明显优于对照组,两组结果相比P<0.05,差异有统计学意义。详细结果见表1。
表1:两组病例治疗后的疗效结果对照表
| 组别 | 例数 | 治愈n(%) | 显效n(%) | 有效n(%) | 无效n(%) | 总有效率(%) |
| 治疗组 | 39 | 8(20.5) | 12(30.8) | 14(35.9) | 5(12.8) | 87.2 |
| 对照组 | 39 | 2(5.1) | 9(23.1) | 16(41.0) | 12(30.8) | 69.2 |
2、副作用比较
观察两组患者治疗过程中的副反应,治疗组未出现明显不良反应,对照组有18例出现胃肠不适反应,在采取对症处理后未影响正常治疗。
结果表明,本发明中药制剂,用于治疗胸椎骨结核症效果确切,治愈率及有效率高,毒副作用小,减少了胸椎结核患者的痛苦及致残率,大大提高了生存质量,患者易于恢复劳动力,值得临床推广和应用。
具体实施方式
实施例1:一种治疗胸椎骨结核的中药制剂,选取熟地20克、肉苁蓉10克、女贞子5克、莱菔子10克、淫羊藿5克、牛膝5克、威灵仙5克、甘草5克、地鳖虫10克、穿山甲8克、全蝎8克、百部8克、葛根8克、杜仲8克、麦芽8克、三七粉8克、红花10克、郁金10克、秦艽8克、元胡10克。
实施例2:一种治疗胸椎骨结核的中药制剂,选取熟地22克、肉苁蓉12克、女贞子6克、莱菔子12克、淫羊藿6克、牛膝6克、威灵仙6克、甘草6克、地鳖虫12克、穿山甲9克、全蝎9克、百部9克、葛根9克、杜仲9克、麦芽9克、三七粉9克、红花11克、郁金11克、秦艽9克、元胡12克。
实施例3:一种治疗胸椎骨结核的中药制剂,选取熟地24克、肉苁蓉14克、女贞子7克、莱菔子14克、淫羊藿7克、牛膝7克、威灵仙8克、甘草7克、地鳖虫14克、穿山甲11克、全蝎9克、百部9克、葛根9克、杜仲8克、麦芽8克、三七粉8克、红花12克、郁金12克、秦艽9克、元胡12克。
实施例4:一种治疗胸椎骨结核的中药制剂,选取熟地26克、肉苁蓉16克、女贞子8克、莱菔子16克、淫羊藿8克、牛膝9克、威灵仙8克、甘草8克、地鳖虫16克、穿山甲12克、全蝎10克、百部10克、葛根11克、杜仲10克、麦芽10克、三七粉11克、红花13克、郁金13克、秦艽10克、元胡13克。
实施例5:一种治疗胸椎骨结核的中药制剂,选取熟地28克、肉苁蓉18克、女贞子9克、莱菔子18克、淫羊藿9克、牛膝9克、威灵仙9克、甘草9克、地鳖虫18克、穿山甲14克、全蝎11克、百部11克、葛根11克、杜仲11克、麦芽11克、三七粉11克、红花14克、郁金14克、秦艽11克、元胡18克。
实施例6:一种治疗胸椎骨结核的中药制剂,选取熟地30克、肉苁蓉20克、女贞子10克、莱菔子20克、淫羊藿10克、牛膝10克、威灵仙10克、甘草10克、地鳖虫20克、穿山甲15克、全蝎12克、百部12克、葛根12克、杜仲12克、麦芽12克、三七粉12克、红花15克、郁金15克、秦艽12克、元胡20克。
下面通过具体病例对本发明的药物疗效进一步进行验证:
病例1
李某,男,36岁。患者一年前无明显诱因开始出现全身疼痛,卧床休息后减轻;夜间痛加重,疼痛可沿脊神经放射,上颈椎放射到后枕部、下颈椎放射到肩或臂。医院检查发现T3-4胸椎出现一定损坏,诊断为胸椎结核。在服用医院开具药物治疗一个月后,症状减轻。但在停药后1周左右,病症复发,患者生活逐渐不能不理,日渐消瘦。经人推荐服用本发明药物治疗,取熟地22克、肉苁蓉12克、女贞子6克、莱菔子12克、淫羊藿6克、牛膝6克、威灵仙6克、甘草6克、地鳖虫12克、穿山甲9克、全蝎9克、百部9克、葛根9克、杜仲9克、麦芽9克、三七粉9克、红花11克、郁金11克、秦艽9克、元胡12克,水煎后服用,每日一剂分早晚口服。治疗一个月后,患者病症明显好转,身体疼痛改善,发热气短等症状消失,下肢肌力逐渐恢复。继续服用2个月后,患者诸症消失,复查T3-4胸椎病变消失。随访半年无复发。
病例2
刘某,男,48岁。患者在10个月前没有任何诱因的出现颈背部疼痛到当地医院检查MRI显示胸2-4椎体结核伴有椎旁肿胀,在当地给予抗结核治疗,无明显好转,胸腰部疼痛加重,且胸腰部,伸展,侧弯受限,行走时加重。在朋友推荐下,服用本发明药物治疗,观察患者症状,取熟地26克、肉苁蓉16克、女贞子8克、莱菔子16克、淫羊藿8克、牛膝9克、威灵仙8克、甘草8克、地鳖虫16克、穿山甲12克、全蝎10克、百部10克、葛根11克、杜仲10克、麦芽10克、三七粉11克、红花13克、郁金13克、秦艽10克、元胡13克,水煎后服用,每日一剂分早晚口服。治疗一个月后,患者身体疼痛改善,活动功能有一定恢复,可以正常行走,下肢肌力逐渐恢复。继续服用2个月后,患者诸症消失,复查胸2-4椎体病变消失。随访半年无复发。
病例3
华某,女,40岁。患者大约在1年前左右无明诱因发生背部疼痛,呈胀痛、刺痛,疼痛剧烈,每次发作持续数分钟到1小时不等,于夜间发作,无恶心,呕吐,无尿频、尿痛及肉眼血尿,到当地医院检查未发现异常,给予止痛剂治疗,无明显好转,此后腰部疼痛时常发作,当市立医院检查后发现:胸8~9椎体结核伴冷脓肿形成,因脓肿面积较大,暂给予异烟肼,利福平、乙胺丁醇,吡嗪酰胺口服,待脓肿局限后手术。服药1月余,腰痛有所缓解,但身体症状改善不明显,由于患者拒绝手术治疗,于是经人推荐开始服用本发明药物治疗。取熟地30克、肉苁蓉20克、女贞子10克、莱菔子20克、淫羊藿10克、牛膝10克、威灵仙10克、甘草10克、地鳖虫20克、穿山甲15克、全蝎12克、百部12克、葛根12克、杜仲12克、麦芽12克、三七粉12克、红花15克、郁金15克、秦艽12克、元胡20克,水煎后服用,每日一剂分早晚口服。治疗一个疗程后,患者腰部疼痛明显改善,可以自行起立,复查显示胸椎兵线及脓肿减小,患者大喜,继续坚持服用本药物两个月后,复查显示病变全部消除,临床治愈。电话随访半年未见复发。
Claims (7)
1.一种治疗胸椎骨结核的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地20-30克、肉苁蓉10-20克、女贞子5-10克、莱菔子10-20克、淫羊藿5-10克、牛膝5-10克、威灵仙5-10克、甘草5-10克、地鳖虫10-20克、穿山甲8-15克、全蝎8-12克、百部8-12克、葛根8-12克、杜仲8-12克、麦芽8-12克、三七粉8-12克、红花10-15克、郁金10-15克、秦艽8-12克、元胡10-20克。
2.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地20克、肉苁蓉10克、女贞子5克、莱菔子10克、淫羊藿5克、牛膝5克、威灵仙5克、甘草5克、地鳖虫10克、穿山甲8克、全蝎8克、百部8克、葛根8克、杜仲8克、麦芽8克、三七粉8克、红花10克、郁金10克、秦艽8克、元胡10克。
3.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地22克、肉苁蓉12克、女贞子6克、莱菔子12克、淫羊藿6克、牛膝6克、威灵仙6克、甘草6克、地鳖虫12克、穿山甲9克、全蝎9克、百部9克、葛根9克、杜仲9克、麦芽9克、三七粉9克、红花11克、郁金11克、秦艽9克、元胡12克。
4.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地24克、肉苁蓉14克、女贞子7克、莱菔子14克、淫羊藿7克、牛膝7克、威灵仙8克、甘草7克、地鳖虫14克、穿山甲11克、全蝎9克、百部9克、葛根9克、杜仲8克、麦芽8克、三七粉8克、红花12克、郁金12克、秦艽9克、元胡12克。
5.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地26克、肉苁蓉16克、女贞子8克、莱菔子16克、淫羊藿8克、牛膝9克、威灵仙8克、甘草8克、地鳖虫16克、穿山甲12克、全蝎10克、百部10克、葛根11克、杜仲10克、麦芽10克、三七粉11克、红花13克、郁金13克、秦艽10克、元胡13克。
6.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地28克、肉苁蓉18克、女贞子9克、莱菔子18克、淫羊藿9克、牛膝9克、威灵仙9克、甘草9克、地鳖虫18克、穿山甲14克、全蝎11克、百部11克、葛根11克、杜仲11克、麦芽11克、三七粉11克、红花14克、郁金14克、秦艽11克、元胡18克。
7.根据权利要求1所述的中药制剂,其特征在于,所述中药制剂由以下重量份的中药原材料组成:
熟地30克、肉苁蓉20克、女贞子10克、莱菔子20克、淫羊藿10克、牛膝10克、威灵仙10克、甘草10克、地鳖虫20克、穿山甲15克、全蝎12克、百部12克、葛根12克、杜仲12克、麦芽12克、三七粉12克、红花15克、郁金15克、秦艽12克、元胡20克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610288822.3A CN105688103A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗胸椎骨结核的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610288822.3A CN105688103A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗胸椎骨结核的中药制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105688103A true CN105688103A (zh) | 2016-06-22 |
Family
ID=56217967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610288822.3A Pending CN105688103A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗胸椎骨结核的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105688103A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435027A (zh) * | 2014-09-20 | 2016-03-30 | 王少朋 | 一种治疗骨结核的中药组合物 |
-
2016
- 2016-05-04 CN CN201610288822.3A patent/CN105688103A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435027A (zh) * | 2014-09-20 | 2016-03-30 | 王少朋 | 一种治疗骨结核的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
| CN101791378B (zh) | 一种用于伤口止血、抗炎、生肌的中药制剂 | |
| CN103495055A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 | |
| CN104547736A (zh) | 一种治疗甲状腺肿的药物 | |
| CN103830482B (zh) | 一种治疗脑卒中的中药制剂及制备方法 | |
| CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
| CN104147194A (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
| CN104383175A (zh) | 一种用于治疗慢性骨髓炎的药物及制备方法 | |
| CN105688103A (zh) | 一种治疗胸椎骨结核的中药制剂 | |
| CN104887970A (zh) | 一种针灸理疗外用药膏 | |
| CN110496200A (zh) | 一种治疗肺结核的中药组合物及其制备方法和应用 | |
| CN104258308A (zh) | 一种治疗胆石症的中药制剂 | |
| CN101732648B (zh) | 一种治疗骨不连的药物 | |
| CN103920042A (zh) | 用于治疗热陷营血型病毒性脑膜炎的药物及其制备方法 | |
| CN103356797A (zh) | 一种治疗肾结石的中药组合物 | |
| CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
| CN107375551A (zh) | 一种治疗脾虚湿蕴型带状疱疹的中药组合物 | |
| CN105125978A (zh) | 一种用于治疗风湿性关节炎的中药制剂及制备方法 | |
| CN105194588A (zh) | 一种治疗肝硬化的中药制剂 | |
| CN105999196A (zh) | 一种用于治疗急性腹膜炎的中药制剂及制备方法 | |
| CN106109928A (zh) | 一种治疗食道炎的药物及制备方法 | |
| CN105687656A (zh) | 一种治疗脊髓炎的药物组合物及制作方法 | |
| CN101129727B (zh) | 一种内服治疗肋间神经痛的中药组合物 | |
| CN105412484A (zh) | 一种治疗关节疼痛的药物及制备方法 | |
| CN105147803A (zh) | 一种治疗肾气亏虚型腰椎管狭窄症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160622 |